학술논문

A phase II trial of lenvatinib in patients with advanced or recurrent endometrial cancer: Angiopoietin-2 as a predictive marker for clinical outcomes
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2013, 31 15, 1p. Supplement: S
Subject
Language
English
ISSN
15277755